<?xml version="1.0" encoding="UTF-8"?>
<ref id="B129-antioxidants-09-01191">
 <label>129.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>K.K.</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Deng</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Shiu</surname>
    <given-names>H.T.</given-names>
   </name>
   <name>
    <surname>Siu</surname>
    <given-names>W.S.</given-names>
   </name>
   <name>
    <surname>Leung</surname>
    <given-names>P.C.</given-names>
   </name>
   <name>
    <surname>Ko</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>Cheng</surname>
    <given-names>B.H.</given-names>
   </name>
  </person-group>
  <article-title>Dihydrofisetin exerts its anti-inflammatory effects associated with suppressing ERK/p38 MAPK and Heme Oxygenase-1 activation in lipopolysaccharide-stimulated RAW 264.7 macrophages and carrageenan-induced mice paw edema</article-title>
  <source>Int. Immunopharmacol.</source>
  <year>2018</year>
  <volume>54</volume>
  <fpage>366</fpage>
  <lpage>374</lpage>
  <pub-id pub-id-type="doi">10.1016/j.intimp.2017.11.034</pub-id>
  <pub-id pub-id-type="pmid">29202300</pub-id>
 </element-citation>
</ref>
